MedTrace Logo

Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma

NCT00327028 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study was evaluation the efficacy of antiepileptic drug phenytoin (diphenine) in the treatment of bronchial asthma.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Diphenine

Sponsors & Collaborators

  • Rea Rehabilitation Centre, Georgia

    collaborator OTHER

  • Centre of Chinese Medicine, Georgia

    lead OTHER

Principal Investigators

  • Tamara Tchelidze, MD · CRO Evidence

  • Manana Pruidze, MD, PhD · Centre of Chinese Medicine

  • Merab Lomia, MD, PhD · "Rea" Rehabilitation Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2005-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00327028 on ClinicalTrials.gov